B
Bfflink
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B | 13 | 8.1 | 5.8 | 10.0 | 16 Dec 2025 |
| ACE-031 | X | 1 | 9.2 | 9.2 | 9.2 | 3 Jul 2025 |
| Aromasin (Exemestane) | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 |
| Botulinum toxin | X | 1 | 5.2 | 5.2 | 5.2 | 24 Apr 2025 |
| BPC157 10mg + TB500 10mg Blend | X | 1 | 9.2 | 9.2 | 9.2 | 16 Mar 2025 |
| BPC157 5mg + TB500 5mg Blend | X | 1 | 10.0 | 10.0 | 10.0 | 13 Feb 2025 |
| CJC-1295 With DAC | X | 1 | 7.4 | 7.4 | 7.4 | 3 Jun 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 8.7 | 8.7 | 8.7 | 21 May 2025 |
| Cortagen | X | 1 | 6.6 | 6.6 | 6.6 | 8 Jul 2025 |
| DHB (1-Test Cyp) Oral | X | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| DHT (Stanolone) | X | 1 | 9.4 | 9.4 | 9.4 | 27 Feb 2025 |
| EPO | X | 1 | 8.2 | 8.2 | 8.2 | 6 May 2025 |
| Hyaluronic acid | X | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
| IGF-1 LR3 | X | 1 | 8.5 | 8.5 | 8.5 | 3 Jul 2025 |
| Ivermectin | X | 1 | 7.9 | 7.9 | 7.9 | 28 Mar 2025 |
| LL37 | X | 1 | 8.3 | 8.3 | 8.3 | 20 Jun 2025 |
| Masteron P (Drostanolone P) | X | 1 | 8.4 | 8.4 | 8.4 | 11 Jun 2025 |
| Methylstenbolone | X | 1 | 7.1 | 7.1 | 7.1 | 17 Dec 2024 |
| Minoxidil Oral | X | 1 | 8.3 | 8.3 | 8.3 | 21 May 2025 |
| MT-1 | X | 1 | 6.8 | 6.8 | 6.8 | 28 Mar 2025 |
| N-Acetyl Epitalon Amidate | X | 1 | 6.8 | 6.8 | 6.8 | 2 Apr 2025 |
| NA Semax Amidate | X | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 |
| NandroMix 300 | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
| Oxymetholone (Anadrol) Raw | X | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 |
| PEG MGF | X | 1 | 7.7 | 7.7 | 7.7 | 13 Feb 2025 |
| PTD-DBM | X | 1 | 6.7 | 6.7 | 6.7 | 11 Jun 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
| Selank | X | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 |
| Semax | X | 1 | 7.2 | 7.2 | 7.2 | 25 Apr 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X | 1 | 8.7 | 8.7 | 8.7 | 20 Jun 2025 |
| SR9009 | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 |
| SS-31 (Elamipretide) Raw | X | 1 | 8.6 | 8.6 | 8.6 | 3 Jul 2025 |
| Tadalafil Raw | X | 1 | 7.0 | 7.0 | 7.0 | 16 Mar 2025 |
| Test Base (No Ester) | X | 1 | 9.7 | 9.7 | 9.7 | 8 Jul 2025 |
| Vesugen | X | 1 | 9.2 | 9.2 | 9.2 | 2 Jul 2025 |
| Winstrol Oil | X | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | IGF-1 LR3 | 8.8 | 30mg | 27.6mg | -7.9% | 99.81% | Lab A |
| 24 May 2026 | Masteron P (Drostanolone P) | 10.0 | 250mg/ml | 296.1mg/ml | +18.4% | 95.88% | Lab F |
| 24 May 2026 | Retatrutide | 9.4 | 30mg | 29.1mg | -3.0% | 99.65% | No Label / Silver Crimp / Blue Cap |
| 24 May 2026 | Retatrutide | 10.0 | 20mg | 19.6mg | -2.0% | 99.90% | No Label / Silver Crimp / Blue Cap |
| 24 May 2026 | NA Semax Amidate | 8.3 | 5mg | 6.2mg | +24.8% | 98.45% | Lab C |
| 24 May 2026 | BPC157 10mg + TB500 10mg Blend | 9.6 | 2mg | 2.2mg | +10.9% | 97.86% | Lab B |
| 24 May 2026 | Methylstenbolone | 7.4 | 50mg | 54.6mg | +9.2% | 97.27% | Lab F |
| 23 May 2026 | Retatrutide | 6.4 | 60mg | 53.4mg | -11.0% | 99.09% | (no data) |
| 23 May 2026 | CJC-1295 With DAC | 7.1 | 5mg | 4.3mg | -14.3% | 97.76% | Lab A |
| 22 May 2026 | Retatrutide | 9.2 | 60mg | 64.4mg | +7.3% | 99.90% | No Label / Silver Crimp / Blue Cap |
| 22 May 2026 | Retatrutide | 7.3 | 20mg | 21.3mg | +6.5% | 99.81% | No Label / Silver Crimp / Blue Cap |
| 22 May 2026 | Retatrutide | 8.7 | 30mg | 28.6mg | -4.7% | 99.37% | White Label / Silver Crimp / Blue Cap |
| 21 May 2026 | Retatrutide | 7.8 | 5mg | 4.45mg | -11.0% | 99.73% | White Label / Silver Crimp / Blue Cap |
| 20 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 9.5 | 1g | 1.2g | +15.4% | 98.92% | Lab C |
| 20 May 2026 | Semax | 7.9 | 10mg | 10.3mg | +2.8% | 96.63% | Lab G |
| 19 May 2026 | BPC157 5mg + TB500 5mg Blend | 9.0 | 10mg | 9.8mg | -2.2% | 95.04% | Lab G |
| 19 May 2026 | Vesugen | 9.5 | 50mg | 57.5mg | +15.0% | 96.78% | Lab G |
| 17 May 2026 | DHB (1-Test Cyp) Oral | 9.8 | 100mg | 103.8mg | +3.8% | 95.62% | Lab G |
| 17 May 2026 | DHT (Stanolone) | 8.5 | 300mg/ml | 361.7mg/ml | +20.6% | 97.76% | Lab D |
| 17 May 2026 | Selank | 8.9 | 10mg | 9.8mg | -2.0% | 97.54% | Lab G |
| 26 Jan 2026 | Aromasin (Exemestane) | 8.5 | 10mg | 10.3mg | +2.5% | 99.94% | Lab E |
| 26 Jan 2026 | EPO | 9.1 | 20mg | 20.1mg | +0.6% | 99.45% | Lab C |
| 26 Jan 2026 | Minoxidil Oral | 7.6 | 20mg | 20.0mg | -0.1% | 97.03% | Lab E |
| 26 Jan 2026 | PEG MGF | 9.5 | 50mg | 55.5mg | +11.1% | 97.06% | Lab A |
| 9 Jan 2026 | Ivermectin | 5.6 | 10mg | 10.6mg | +6.5% | 97.68% | Lab C |
| 9 Jan 2026 | SR9009 | 5.8 | 10mg | 11.7mg | +17.4% | 98.32% | Lab C |
| 7 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.6 | 20mg | 24.0mg | +19.8% | 96.44% | Lab E |
| 6 Jan 2026 | N-Acetyl Epitalon Amidate | 8.3 | 5mg | 6.1mg | +22.3% | 98.29% | Lab F |
| 29 Dec 2025 | Hyaluronic acid | 7.5 | 50mg | 55.1mg | +10.3% | 95.54% | Lab D |
| 12 Dec 2025 | NandroMix 300 | 7.4 | 200mg/ml | 174.0mg/ml | -13.0% | 98.83% | Lab E |
| 12 Dec 2025 | SS-31 (Elamipretide) Raw | 10.0 | 1g | 0.9g | -13.4% | 96.22% | Lab E |
| 12 Dec 2025 | Test Base (No Ester) | 10.0 | 300mg/ml | 306.0mg/ml | +2.0% | 99.41% | Lab A |
| 12 Dec 2025 | Winstrol Oil | 7.4 | 300mg/ml | 319.6mg/ml | +6.5% | 95.93% | Lab B |
| 5 Dec 2025 | Oxymetholone (Anadrol) Raw | 6.3 | 10g | 11.5g | +14.7% | 97.05% | Lab B |
| 17 Nov 2025 | Cortagen | 6.2 | 2mg | 1.9mg | -5.5% | 97.57% | Lab F |
| 17 Nov 2025 | PTD-DBM | 6.2 | 5mg | 5.6mg | +11.7% | 96.46% | Lab D |
| 17 Nov 2025 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 6.2 | 100mg/ml | 110.8mg/ml | +10.8% | 97.13% | Lab F |
| 14 Nov 2025 | LL37 | 7.0 | 30mg | 32.9mg | +9.8% | 97.94% | Lab D |
| 14 Nov 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 8.9 | 20mg | 18.9mg | -5.4% | 99.37% | Lab A |
| 14 Nov 2025 | Tadalafil Raw | 5.9 | 1g | 1.0g | -1.1% | 96.71% | Lab D |
| 17 Oct 2025 | ACE-031 | 10.0 | 2mg | 1.8mg | -10.1% | 98.25% | Lab A |
| 17 Oct 2025 | Botulinum toxin | 4.2 | 5mg | 4.8mg | -3.1% | 96.44% | Lab F |
| 3 Oct 2025 | MT-1 | 7.5 | 30mg | 26.5mg | -11.8% | 95.51% | Lab B |